These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23079076)

  • 1. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Pro position.
    Agarwal RL
    J Am Soc Hypertens; 2012; 6(6):439-42. PubMed ID: 23079076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position.
    Weir MR
    J Am Soc Hypertens; 2012; 6(6):443-7. PubMed ID: 23127361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.
    Thompson S; Hemmelgarn B; Wiebe N; Majumdar S; Klarenbach S; Jindal K; Manns B; Mortis G; Campbell P; Tonelli M;
    J Nephrol; 2012; 25(6):944-53. PubMed ID: 23147684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension in dialysis: up to what point should it be corrected? A lot!].
    Genovesi S
    G Ital Nefrol; 2011; 28(3):256-60. PubMed ID: 21626492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension is harmful to dialysis patients and should be controlled.
    Foley RN; Agarwal R
    Semin Dial; 2007; 20(6):518-22. PubMed ID: 17991197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities.
    Agarwal R
    Kidney Int; 2005 Jan; 67(1):1-13. PubMed ID: 15610223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in end-stage renal disease: different measures and their prognostic significance.
    Hörl WH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3161-6. PubMed ID: 20685828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.